Literature DB >> 2867545

Pertussis toxin is required for pertussis vaccine encephalopathy.

L Steinman, A Weiss, N Adelman, M Lim, R Zuniga, J Oehlert, E Hewlett, S Falkow.   

Abstract

A mouse model for encephalopathy induced by pertussis immunization has been described; it has features that closely resemble some of the severe reactions, including seizures and a shock-like state leading to death, occasionally seen after administration of Bordetella pertussis (whooping cough) vaccine. Susceptibility to encephalopathy maps to genes of the major histocompatibility complex and correlates as well with the genetic regulation of the level of antibody response to bovine serum albumin. In this study we have investigated which bacterial determinant is responsible for the encephalopathy. Two lines of evidence implicate pertussis toxin as the active bacterial component. Single-site mutants of B. pertussis with single affected virulence factors were tested. A mutant that produces a defective pertussis toxin had greatly diminished capacity to induce encephalopathy, whereas a hemolysin- and adenylate-cyclase-deficient avirulent mutant had the same activity in the mouse model as a virulent strain. Purified pertussis toxin plus bovine serum albumin was tested and found to induce the lethal encephalopathy, demonstrating that the toxin was the critical constituent of B. pertussis responsible for encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867545      PMCID: PMC391511          DOI: 10.1073/pnas.82.24.8733

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  ANTI-BOVINE SERUM ALBUMIN AND ANTI-ALPHA LACTALBUMIN IN THE SERUM OF CHILDREN AND ADULTS.

Authors:  R M ROTHBERG; R S FARR
Journal:  Pediatrics       Date:  1965-04       Impact factor: 7.124

2.  Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

3.  Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein.

Authors:  T Katada; M Ui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.

Authors:  E L Hewlett; K T Sauer; G A Myers; J L Cowell; R L Guerrant
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  Murine model for pertussis vaccine encephalopathy: linkage to H-2.

Authors:  L Steinman; S Sriram; N E Adelman; S Zamvil; H O McDevitt; H Urich
Journal:  Nature       Date:  1982-10-21       Impact factor: 49.962

6.  Immune responses of normal infants to cow milk. I. Antibody type and kinetics of production.

Authors:  B Kletter; I Gery; S Freier; A M Davies
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

7.  Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin.

Authors:  R L Riley; L D Wilson; R N Germain; D C Benjamin
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Pertussis immunisation and serious acute neurological illness in children.

Authors:  D L Miller; E M Ross; R Alderslade; M H Bellman; N S Rawson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

9.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124

10.  Biological activities of crystalline pertussigen from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R K Bergman; P L Sadowski
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

View more
  21 in total

Review 1.  Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire.

Authors:  L Steinman
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.

Authors:  M A Schmidt; B Raupach; M Szulczynski; J Marzillier
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

4.  Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose.

Authors:  G D Armstrong; M S Peppler
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence.

Authors:  M K Gross; D C Au; A L Smith; D R Storm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

6.  Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.

Authors:  M Pizza; A Bartoloni; A Prugnola; S Silvestri; R Rappuoli
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.

Authors:  Jamie N Sutherland; Christine Chang; Sandra M Yoder; Michael T Rock; Jennifer A Maynard
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

Review 8.  Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients.

Authors:  E L Hewlett; J L Cowell
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

9.  Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin.

Authors:  Y Lobet; W Cieplak; S G Smith; J M Keith
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

10.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Authors:  L Nencioni; M Pizza; M Bugnoli; T De Magistris; A Di Tommaso; F Giovannoni; R Manetti; I Marsili; G Matteucci; D Nucci
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.